AwardTape · Defense awards · Medical · Drugs and biologicals · HT942525P0074
HT942525P0074: $100K purchase order to Octapharma USA Inc
Octapharma USA Inc holds a purchase order from Defense Health Agency with $100K obligated since Oct 2023, against a ceiling of $100K. Latest action May 23, 2025.
Octaplaslg for white house medical unit
| PIID | HT942525P0074 |
|---|---|
| Type | purchase order |
| Company | Octapharma USA Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING |
| Obligated since Oct 2023 | $100K |
| Total obligated (lifetime) | $100K |
| Ceiling (base and all options) | $100K |
| Base date | May 23, 2025 |
| Latest action | May 23, 2025 |
| End date | Jun 8, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial